Skip to main content
TipRanks
Go Ultimate75% OFF

Lumibird SA (LBIRD) AI Stock Analysis

8 Followers
FR:LBIRD

Lumibird SA

(Paris:LBIRD)

Select Model
Rating:66Neutral
Price Target:EUR 26.00â–²(5.05% Upside)
Action:downgraded
Date:08/19/26

The overall score is driven primarily by solid revenue growth and improving profitability, offset by volatile cash flows and only moderate returns on equity, while a supportive but measured technical uptrend adds a secondary positive factor and a premium valuation limits upside.

Positive Factors
Steady Revenue GrowthSteady revenue expansion indicates continued demand for Lumibird’s photonics products across its industrial, defense, and life-science markets. This supports a durable base for investment, customer development, and operating leverage over the next several quarters.
Negative Factors
Volatile Free Cash FlowThe history of negative and uneven free cash flow indicates that reported earnings have not consistently translated into discretionary cash. This can constrain self-funded investment, increase reliance on financing, and make durable cash generation less predictable during growth periods.

Lumibird SA (LBIRD) vs. iShares MSCI France ETF (EWQ)

-10%0%10%20%30%40%FR:LBIRD+19.20%EWQ+2.16%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 536.34M
Dividend Yield
1.49%
Average Volume (3M)
31.35K
Price to Earnings (P/E)
39.3
Beta (1Y)
0.47
Revenue Growth
8.13%
EPS Growth
31.36%
Country
France
Employees
1,078
Sector
General
Sector Strength
55
Industry
Hardware, Equipment & Parts

Lumibird SA Business Overview & Revenue Model

Company Description

A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The comp...

How the Company Makes Money

Lumibird makes money primarily by selling photonics hardware and related solutions to customers in industry, defense, and healthcare/life-science markets. Key revenue streams generally include: (1) Product sales of laser sources and laser subsystems—...

Lumibird SA Financial Statement Overview

Summary

Healthy revenue growth and improving profitability in 2025, supported by a solid equity base, but modest returns on equity and volatile cash flows limit confidence in long-term earnings quality.

Income Statement

72Positive

Balance Sheet

65Positive

Cash Flow

60Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue236.41M228.53M210.06M206.55M194.29M162.47M
Gross Profit157.03M146.24M16.06M128.11M15.36M18.49M
EBITDA36.61M44.32M31.03M27.31M32.09M31.81M
Net Income14.19M14.00M5.70M7.13M11.35M13.86M
Balance Sheet
Total Assets434.70M428.90M429.80M405.25M372.04M347.62M
Cash, Cash Equivalents and Short-Term Investments58.20M61.60M71.14M56.20M61.68M97.13M
Total Debt150.80M146.20M161.06M145.08M114.18M112.03M
Total Liabilities226.90M222.60M231.79M211.95M178.61M166.29M
Stockholders Equity207.80M206.30M198.01M193.30M193.44M181.33M
Cash Flow
Free Cash Flow673.00K12.64M11.41M-4.89M-28.02M6.47M
Operating Cash Flow17.43M29.00M34.37M20.67M1.43M26.57M
Investing Cash Flow-16.93M-15.90M-22.84M-46.15M-29.34M-28.63M
Financing Cash Flow-8.07M-22.16M3.39M21.69M-7.89M18.20M

Lumibird SA Technical Analysis

Technical Analysis SentimentPositive
Last Price24.75

Price Trends

50DMA24.12Positive
100DMA25.34Negative
200DMA24.09Positive

Market Momentum

MACD0.27Negative
RSI55.19Neutral
STOCH82.76Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LBIRD, the sentiment is Positive. The current price of 24.75 is above the 20-day moving average (MA) of 24.00, above the 50-day MA of 24.12, and above the 200-day MA of 24.09, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 55.19 is Neutral, neither overbought nor oversold. The STOCH value of 82.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LBIRD.

Lumibird SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

FR:LBIRD against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:BIMFR:BIM73OutperformEUR 10.90B23.6111.01%1.06%-3.18%22.52%
FR:DIMFR:DIM69NeutralEUR 21.68B66.837.71%0.31%3.90%22.74%
FR:LBIRDFR:LBIRD66NeutralEUR 550.35M39.286.85%1.49%8.13%31.36%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
FR:ALTHEFR:ALTHE46NeutralEUR 46.78M-5.74453.10%―-16.98%20.31%
FR:ALMDTFR:ALMDT43NeutralEUR 208.54M-3.54271.64%―2.16%-5.26%
FR:ALMKTFR:ALMKT41NeutralEUR 18.02M1.46-157.72%―3.38%―

* General Sector Average

Performance Comparison

0%50%100%150%FR:LBIRDFR:BIMFR:ALMKTFR:DIMFR:ALTHEFR:ALMDTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:LBIRD and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:LBIRDLumibird SA24.753.5916.98%
FR:BIMbioMerieux SA92.80-12.16-11.58%
FR:ALMKTMAUNA KEA TECHNOLOGIES0.090.019.52%
FR:DIMSartorius Stedim Biotech223.2033.9217.92%
FR:ALTHETheraclion SA0.59-0.09-12.65%
FR:ALMDTMedian Technologies4.361.4047.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 30, 2026